强生宣布焕新品牌，整合医疗科技与制药业务

DoNews2023-09-15

DoNews9月15日消息，14日，强生宣布品牌焕新，将旗下医疗科技和制药两大业务整合至强生（Johnson & Johnson）名下，彰显公司在医疗健康领域的跨业务综合实力，持续促进医疗健康创新，解决最严峻的健康挑战，推动全球健康事业发展。基于公司在创新制药和医疗科技两方面的行业专长，全新强生将致力于推动复杂疾病能够得到预防、诊疗和治愈，带来更智能、创伤更小和更个性化的医疗解决方案。未来，强生...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2367989136?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2023-09-15 14:54","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2367989136","market":"us","top_or_hot":-1,"title":"强生宣布焕新品牌，整合医疗科技与制药业务","media":"DoNews","content":"<div>\n<p>DoNews9月15日消息，14日，强生宣布品牌焕新，将旗下医疗科技和制药两大业务整合至强生（Johnson & Johnson）名下，彰显公司在医疗健康领域的跨业务综合实力，持续促进医疗健康创新，解决最严峻的健康挑战，推动全球健康事业发展。基于公司在创新制药和医疗科技两方面的行业专长，全新强生将致力于推动复杂疾病能够得到预防、诊疗和治愈，带来更智能、创伤更小和更个性化的医疗解决方案。未来，强生...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230915145452824c781d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>强生宣布焕新品牌，整合医疗科技与制药业务</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n强生宣布焕新品牌，整合医疗科技与制药业务\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-09-15 14:54 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230915145452824c781d&s=b><strong>DoNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DoNews9月15日消息，14日，强生宣布品牌焕新，将旗下医疗科技和制药两大业务整合至强生（Johnson & Johnson）名下，彰显公司在医疗健康领域的跨业务综合实力，持续促进医疗健康创新，解决最严峻的健康挑战，推动全球健康事业发展。基于公司在创新制药和医疗科技两方面的行业专长，全新强生将致力于推动复杂疾病能够得到预防、诊疗和治愈，带来更智能、创伤更小和更个性化的医疗解决方案。未来，强生...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230915145452824c781d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230915145452824c781d&s=b","article_id":"2367989136","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230915145452824c781d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2367989136","pubTimestamp":1694760886,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"DoNews9月15日消息，14日，强生宣布品牌焕新，将旗下医疗科技和制药两大业务整合至强生 名下，彰显公司在医疗健康领域的跨业务综合实力，持续促进医疗健康创新，解决最严峻的健康挑战，推动全球健康事业发展。未来，强生公司的两大业务将更紧密地联结在强生品牌下，公司制药业务杨森将更名为强生创新制药，强生医疗科技则保持不变。这一全新的品牌色调也传达出强生快速响应健康挑战的能力，彰显公司与时俱进、持续引领行业发展的雄心。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4585":"ETF&股票定投概念","LU0912757837.SGD":"JPMorgan Investment Funds - Global Income A (mth) SGD-H","BK4534":"瑞士信贷持仓","LU1244550221.USD":"FRANKLIN GLOBAL MULTI-ASSET  INCOME \"A\" (USDHEDGED) INC (M)","JNJ":"强生","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU0889566641.SGD":"FTSF - Templeton Shariah Global Equity A Acc SGD","SG9999002232.USD":"Allianz Global High Payout USD","BK4533":"AQR资本管理(全球第二大对冲基金)","LU1732799900.SGD":"JPMorgan Investment Funds - Global Income A (irc) SGD-H","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU0795875169.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD-H","BK4592":"伊斯兰概念","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","BK4504":"桥水持仓","BK4559":"巴菲特持仓","LU1732800096.USD":"摩根大通环球收益基金A (irc)","BK4568":"美国抗疫概念","LU1244550577.SGD":"FTIF - Franklin Global Multi-Asset Income A (Mdis) SGD-H1","LU1074936037.SGD":"JPMorgan Funds - US Value A (acc) SGD","BK4588":"碎股","BK4550":"红杉资本持仓","LU0234572021.USD":"高盛美国核心股票组合Acc","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU0122379950.USD":"贝莱德世界健康科学A2","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","BK4007":"制药","LU1261432733.SGD":"Fidelity World A-ACC-SGD","LU1032466523.USD":"高盛全球多资产收益组合Acc","LU1935042991.SGD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME  \"AA\" (SGDHDG) INC","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU0792757196.USD":"TEMPLETON SHARIAH GLOBAL EQUITY FUND \"A\" (USD) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU1244550494.USD":"FRANKLIN GLOBAL MULTI-ASSET INCOME \"A\" (USDHEDGED) ACC","LU0795875086.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD","LU2347655156.SGD":"JPMorgan Investment Funds - Global Income A (icdiv) SGD-H","BK4532":"文艺复兴科技持仓","LU1267930813.SGD":"FRANKLIN TEMPLETON SHARIAH GLOBAL EQUITY \"AS\" (SGD) ACC","BK4581":"高盛持仓","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","LU2133065610.SGD":"JPMorgan Investment Funds - Global Dividend A (mth) SGD","SG9999002224.SGD":"Allianz Global High Payout SGD"},"translate_title":"Johnson & Johnson announced the rejuvenation of its brand and the integration of medical technology and pharmaceutical business","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JNJ":1},"content_text":"DoNews9月15日消息，14日，强生宣布品牌焕新，将旗下医疗科技和制药两大业务整合至强生（Johnson & Johnson）名下，彰显公司在医疗健康领域的跨业务综合实力，持续促进医疗健康创新，解决最严峻的健康挑战，推动全球健康事业发展。基于公司在创新制药和医疗科技两方面的行业专长，全新强生将致力于推动复杂疾病能够得到预防、诊疗和治愈，带来更智能、创伤更小和更个性化的医疗解决方案。未来，强生公司的两大业务将更紧密地联结在强生品牌下，公司制药业务杨森将更名为强生创新制药（Johnson & Johnson Innovative Medicine），强生医疗科技（Johnson & Johnson MedTech）则保持不变。全新的强生品牌标识在传承了公司悠久历史的的基础上，更突出关键元素的现代感，以更加包容的方式展示强生在医疗健康领域的创新，以及对生命充满温暖和关爱的特质。全新的品牌标识展现出公司开启新篇章的现代感。每个英文字母以清晰简练的方式书写排列，传递出令人耳目一新和富有人文关怀的感受。未来，强生将使用全称和缩写两种品牌标识，并且在数字化界面等应用场景中凸显缩写的品牌标识“J&J”更具亲和力和现代感的特质。全新品牌标识还将以动态形式呈现，适用于更多元化的应用场景。强生公司将继续延用红色作为主视觉色，并启用焕新、明亮和更富现代气息的红色。这一全新的品牌色调也传达出强生快速响应健康挑战的能力，彰显公司与时俱进、持续引领行业发展的雄心。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2367989136","isCrawlerRequest":true}